Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload.
about
A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophyNuclear compartmentalization of α1-adrenergic receptor signaling in adult cardiac myocytesVasodilator therapy with hydralazine induces angiotensin AT receptor-mediated cardiomyocyte growth in mice lacking guanylyl cyclase-A.Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodentsThyroid Hormone Increases TGF-beta1 in Cardiomyocytes Cultures Independently of Angiotensin II Type 1 and Type 2 Receptors.Addressing those two that go together: the angiotensin II receptors and their role in blood-flow regulation.Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.Foetal hypoxia increases cardiac AT(2)R expression and subsequent vulnerability to adult ischaemic injury.Angiotensin AT2 receptors: cardiovascular hope or hype?Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Angiotensin II and oxidative stress in the failing heartAT(2) receptor and tissue injury: therapeutic implications.Cardiovascular effects of losartan and its relevant clinical application.Adapter proteins and promoter regulation of the angiotensin AT2 receptor--implications for cardiac pathophysiology.The angiotensin II type 2 receptor in cardiovascular disease.Angiotensin II type 2 receptor gene polymorphisms in cardiovascular disease.Morphological and molecular changes of the myocardium after left ventricular mechanical supportGenetically modified mouse models used for studying the role of the AT2 receptor in cardiac hypertrophy and heart failure.Angiotensin II type 2 receptor agonists: where should they be applied?Function and expression of ATIP and its variants in cardiomyoblast cell line H9c2.The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1.High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive ratsApoptosis after reperfused myocardial infarction: Role of angiotensin II.Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction.Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes.Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice.Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice.Protective effects of tannic acid on pressure overload-induced cardiac hypertrophy and underlying mechanisms in rats.TGF-beta1 in SP-A preparations influence immune suppressive properties of SP-A on human CD4+ T lymphocytes.Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing.
P2860
Q24634320-A9CE3394-F762-4D4A-8CCF-87E7AF2738F8Q27015977-6FBDACBD-610E-4D42-8D0F-7153CD5D33CAQ33730624-447F2CBD-0EC4-4F22-BEC2-9B778171574AQ33755314-302F720A-6F20-4BEB-A64A-EE0A06A0271AQ33960840-763B968D-2358-432D-848D-03BEF3189C45Q34238307-89D57F65-788E-470F-9DFA-DF7536264977Q34256543-207A2B73-BB4B-41EE-BFD5-EE9FB58B4377Q34485828-EF43C9B9-8CE8-4DE5-BDD1-2B51EA2BBBBEQ35045801-6B86A19B-C449-4347-89DB-D5FB235EF23EQ36067015-A345FC1F-45A0-49FF-9D1C-68A0DD42B18FQ36241932-B75D4550-A9CF-4E73-AA5D-CC1DF5A1FA72Q37166953-8720A330-0C30-4DD0-A669-768F9521B373Q37531017-E978A081-A5F9-40CC-BD06-AAB4B51959CFQ37595599-EB35FBD5-5918-4D06-B118-60C40BF3CC81Q37598488-37E49F61-2CAB-437B-AF8B-0A662C807AEEQ37622575-909F2E10-B69A-4BCB-8D31-3E4672835599Q37622578-ED61F707-9782-4CE9-BEA6-0765AF01CA31Q37638247-66F63A93-5505-496D-AC4C-BE5D4326EB75Q37871869-D5148827-1244-4C83-9DBC-149007FC9C04Q37986143-21B740C6-1D38-4622-AFB2-E4DBF7CDFB55Q39170846-C811596F-5893-4407-A7A2-199DDF9E1919Q39376362-17F0EF88-9528-4E8A-8D8C-F2EF29010993Q39737699-92C19170-0A95-444A-930C-9446E33335C4Q41953838-FDBCFFB8-3A1B-4C24-B01B-0920FD738077Q42078470-C591DBC7-5D64-4809-98A6-AD6161B1496AQ43799989-4E376437-AF19-41CB-9E7B-577FFC3A19D3Q45063927-DEBF456F-BEA9-4423-B8EA-60D6237132BEQ46820254-7F6DC85B-BEED-4B0C-8D00-1C739CA54CACQ47316917-845E60E9-140A-40C5-9079-6DCEBD96635DQ47752119-EDCD4D42-DDF9-40B5-9FD8-F2E5E03BBBD7Q48251701-8D50DF1D-5355-4145-A152-6A67171924B2Q51808061-EA10DC79-6B80-4574-82CE-EFCA02206E88Q52937062-3687FDDC-375C-4955-8518-8E67404D51EE
P2860
Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Evidence for angiotensin II ty ...... ing in vivo pressure overload.
@en
type
label
Evidence for angiotensin II ty ...... ing in vivo pressure overload.
@en
prefLabel
Evidence for angiotensin II ty ...... ing in vivo pressure overload.
@en
P2093
P2860
P356
P1476
Evidence for angiotensin II ty ...... ing in vivo pressure overload.
@en
P2093
F A Gaffney
S Ichihara
T Senbonmatsu
P2860
P356
10.1172/JCI10037
P407
P577
2000-08-01T00:00:00Z